© The Canadian Journal of Urology™; 21(Supplement 2); June 2014
53
Testosterone deficiency: myth, facts, and controversy
20. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum
testosterone andmortality in older men.
J Clin Endocrinol Metab
2008;93(1):68-75.
21. Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic
use, abuse, andnonmedical use of opioids: a ten-year perspective.
Pain Physician
2010;13(5):401-435.
22. CovielloAD,MatsumotoAM,BremnerWJetal.Low-dosehuman
chorionic gonadotropin maintains intratesticular testosterone
in normal men with testosterone-induced gonadotropin
suppression.
J Clin Endocrinol Metab
2005;90(5):2595-2602.
23. Dhindsa S, Miller MG, McWhirter ML et al. Testosterone
concentrations in diabetic and nondiabetic obese men.
Diabetes
Care
2010;33(6):1186-1192.
24. Hak AE, Witteman JC, de Jong FH, Geerlings MI, Hofman A,
Pols HA. Low levels of endogenous androgens increase the risk
of atherosclerosis in elderly men: the Rotterdam study.
J Clin
Endocrinol Metab
2002;87(8):3632-3639.
25. YeapBB,HydeZ,NormanPE,ChubbSAP,GolledgeJ.Associations
of total testosterone, sex hormone-binding globulin, calculated
free testosterone, and luteinizing hormone with prevalence of
abdominal aortic aneurysm in older men.
J Clin Endocrinol Metab
2010;95(3):1123-1130.
26. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum
testosterone andmortality in older men.
J Clin Endocrinol Metab
2008;93(1):68-75.
27. TivestenA, Vandenput L, Labrie F et al. Low serum testosterone
and estradiol predict mortality in elderly men.
J Clin Endocrinol
Metab
2009;94(7):2482-2488.
28. Thompson IM, Tangen CM, Goodman PJ, Probstfield JL,
Moinpour CM, ColtmanCA. Erectile dysfunction and subsequent
cardiovascular disease.
JAMA
2005;294(23):2996-3002.
29. Qaseem A, Snow V, Denberg TD et al. Hormonal testing and
pharmacologic treatment of erectile dysfunction: a clinical
practice guideline from the American College of Physicians.
Ann Intern Med
2009;151(9):639-649.
30. EdelsteinD,DobsA,BasariaS.Emergingdrugsforhypogonadism.
Expert Opin Emerg Drugs
2006;11(4):685-707.
31. Gooren LJ, Behre HM, Saad F, FrankA, Schwerdt S. Diagnosing
and treating testosterone deficiency in different parts of the
world.Resultsfromglobalmarketresearch.
AgingMale
2007;10(4):
173-181.
32. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position
Statement: Utility, limitations, and pitfalls in measuring
testosterone: an Endocrine Society position statement.
J Clin
Endocrinol Metab
2007;92(2):405-413.
33. Rosen RC, AraujoAB, Connor MK et al. Assessing symptoms of
hypogonadism by self-administered questionnaire: qualitative
findings in patients and controls.
AgingMale
2009;12(2-3):77-85.
34. RosenRC,AraujoAB, ConnorMKet al. TheNERI hypogonadism
screener: psychometric validation inmale patients and controls.
Clin Endocrinol
2011;74(2):248-256.
35. Morgentaler A. Testosterone and prostate cancer: what are the
risks for middle-aged men?
Urol Clin N Am
2011;38(2):119-124.
36. Morgentaler A, Lipshultz LI, Bennett R, Sweeney M, Avila D Jr,
Khera M. Testosterone therapy in men with untreated prostate
cancer.
J Urol
2011;185(4):1256-1260.
37. Miner MM. Low testosterone medscape CME expert column
series. issue 1: testosterone deficiency in men: common and
under-recognized. 2011. Available at:
.
medscape.org/viewarticle/746602. Accessed August 3, 2011.
38. Corona G, Rastrelli G, Forti G, Maggi M. Update in testosterone
therapy for men (CME).
J Sex Med
2011;8(3):639-654.
39. MinerMM, SadovskyR. Evolving issues inmale hypogonadism:
evaluation, management, and related comorbidities.
Cleveland
Clin J Med
2007;74(Suppl 3):S38-S46.
40. Dandona P, Rosenberg MT. A practical guide to male
hypogonadism in the primary care setting.
Int J Clin Pract
2010;
64(6):682-696.
41. Swerdloff RS, Wang C. The testis and male sexual function. In:
Goldman L, Ausiello D, eds. Goldman: Cecil Medicine. 23
rd
ed.
Philadelphia, PA: Saunders Elsevier 2008:253.
42. Arver S, Lehtihet M. Current guidelines for the diagnosis of
testosterone deficiency.
Front Horm Res
2009;37:5-20.
43. Bassil N, Morley JE. Late-life onset hypogonadism: a review.
Clin Geriatr Med
2010;26(2):197-222.
44. Buvat J, Maggi M, Gooren L et al. Endocrine aspects of male
sexual dysfunctions.
J Sex Med
2010;7(4 Pt 2):1627-1656.
45. Emmelot-Vonk MH, Verhaar HJ et al. Low testosterone
concentrations and the symptoms of testosterone deficiency
according to theAndrogenDeficiency inAgeingMales (ADAM)
andAgeingMales’ Symptoms rating scale (AMS) questionnaires.
Clin Endocrinol (Oxf)
2011;74(4):488-494.
46. Morley JE, Perry HM 3
rd
, Kevorkian RT, Patrick P. Comparison
of screening questionnaires for the diagnosis of hypogonadism.
Maturitas
2006;53(4):424-429.
47. AmSocietyAndrol Position Statement: Testosterone Deficiency.
J Androl
2006;27(2):133-134.
48. CitronJT,EttingerB,RubinoffHetal.Prevalenceofhypothalamic-
pituitary imaging abnormalities in impotentmenwith secondary
hypogonadism.
J Urol
1996;155(2):529-533.
49. Zitzmann M, Faber S, Nieschlag E. Association of specific
symptoms andmetabolic risks with serum testosterone in older
men.
J Clin Endocrinol Metab
2006;91(11):4335-4343.
50. Lackner JE, Rücklinger E, Schatzl G, Lunglmayr G, Kratzik CW.
Are there symptom-specific testosterone thresholds in aging
men?
BJU Int
2011;108(8):1310-1315.
51. Traish AM, Miner MM, Morgentaler A, Zitzmann M.
Testosterone deficiency.
Am J Med
2011;124(7):578-587.
52. AaronsonAJ, Morrissey RP, Nguyen CT, Willix R, Schwarz ER.
Update on the safety of testosterone therapy in cardiac disease.
Expert Opin Drug Saf
2011;10(5):697-704.
53. LunenfeldB, NieschlagE. Testosterone therapy in the agingmale.
Aging Male
. 2007;10(3):139-153.
54. Yeap BB, Almeida OP, Hyde Z et al. Healthier lifestyle predicts
higher circulating testosterone in older men: the Health InMen
Study.
Clin Endocrinol
2009;70(3):455-463.
55. Heufelder AE, Saad F, Bunck MC, Gooren L. Fifty-two-week
treatment with diet and exercise plus transdermal testosterone
reverses themetabolic syndrome and improves glycemic control
in men with newly diagnosed type 2 diabetes and subnormal
plasma testosterone.
J Androl
2009;30(6):726-733.
56. Bhasin S, Basaria S. Diagnosis and treatment of hypogonadism
in men.
Best Pract Res Clin Endocrinol Metab
2011;25(2):251-270.
57. IsidoriAM,GiannettaE,GianfrilliD,etal.Effectsoftestosteroneon
sexual function inmen: results of ameta-analysis.
Clin Endocrinol
(Oxf)
2005;63(4):381-394.
58. Permpongkosol S, Tantirangsee N, Ratana-olarn K. Treatment
of 161 men with symptomatic late onset hypogonadism with
long-acting parenteral testosterone undecanoate: effects on
bodycomposition,lipids,andpsychosexualcomplaints.
JSexMed
2010;7(11):3765-3774.
59. Morgentaler A. A 66-year-old man with sexual dysfunction.
JAMA
2004;291(24):2994-3003.
60. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H.
Randomized study of testosterone gel as adjunctive therapy
to sildenafil in hypogonadal men with erectile dysfunction
who do not respond to sildenafil alone.
J Urol
2004;172(2):
658-663.
61. KennyAM, PrestwoodKM, GrumanCA,MarcelloKM, RaiszLG.
Effects of transdermal testosterone on bone andmuscle in older
men with low bioavailable testosterone levels.
J Gerontol A Biol
Sci Med Sci
2001;56(5):M266-M272.
62. Isidori AM, Giannetta E, Greco EA et al. Effects of testosterone
on body composition, bone metabolism and serum lipid profile
inmiddle-agedmen: ameta-analysis.
Clin Endocrinol (Oxf)
2005;
63(3):280-293.
